"Reduced L-selectin (CD62LLow) expression identifies tumor-specific type 1 T cells from lymph nodes draining an autologous tumor cell vaccine" by Sybren L. Meijer

Selected Works of Walter J. Urba, MD, PhD

Article

Reduced L-selectin (CD62LLow) expression identifies tumor-specific type 1 T cells from lymph nodes draining an autologous tumor cell vaccine

Cellular Immunology (2004)

Sybren L. Meijer, Providence Portland Medical Center
Annemieke Dols, Providence Portland Medical Center
Hong-Ming Hu, Providence Portland Medical Center
Yiwei Chu, Providence Portland Medical Center
Pedro Romero, Ludwig Institute for Cancer Research
Walter J. Urba, Providence Portland Medical Center
Bernard A. Fox, Providence Portland Medical Center

Link

Disciplines

Biology and
Immunology and Infectious Disease

Publication Date

January 2, 2004

DOI

10.1016/j.cellimm.2004.01.006

Citation Information

Sybren L. Meijer, Annemieke Dols, Hong-Ming Hu, Yiwei Chu, et al.. "Reduced L-selectin (CD62LLow) expression identifies tumor-specific type 1 T cells from lymph nodes draining an autologous tumor cell vaccine" Cellular Immunology Vol. 227 Iss. 2 (2004) p. 93 - 102
Available at: http://works.bepress.com/walter-urba/212/